Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Guanosine pentaphosphate (ppGpp) is a purine nucleotide derivative and a central bacterial signaling molecule, classified as an alarmone, that mediates the stringent response in prokaryotes[1][3][5]. In response to nutrient or environmental stresses, ppGpp rapidly accumulates and reorganizes gene expression by altering transcriptional and translational profiles[1][3][7]. ppGpp regulates essential processes: it binds bacterial RNA polymerase to inhibit rRNA and tRNA synthesis, controls DNA replication, inhibits translation initiation, and coordinates cellular metabolism to improve survival under adverse conditions by promoting dormancy and stress resistance[1][5][7]. Collectively, these functions underlie processes such as antibiotic persistence, immune evasion, and virulence in pathogenic bacteria[5]. ppGpp is most prominent in bacteria but is also found in plant chloroplasts[1][6]. While highly conserved and studied as a bacterial physiological and virulence regulator, ppGpp itself is not conventionally considered a therapeutic target as a receptor, enzyme, transporter, or transcription factor. However, enzymes regulating its synthesis and degradation (\"RelA\", \"SpoT\" in Gram-negatives; \"Rel\" in Gram-positives)[3][8], rather than ppGpp directly, are being investigated as potential antimicrobial targets due to their roles in pathogen adaptation and persistence. The abbreviation (p)ppGpp refers to both guanosine tetraphosphate (ppGpp) and guanosine pentaphosphate (pppGpp), which have similar but distinct roles[1][3][5]. While not a classical target by strict modern pharmacological definitions, understanding and modulating the enzymes responsible for ppGpp metabolism may be therapeutically relevant, especially in fighting bacterial persistence and antibiotic tolerance[5].
Not applicable (ppGpp is not a conventional drug target; it is a signaling metabolite)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Guanosine pentaphosphate (ppGpp).